Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spontaneous remission in diffuse large cell lymphoma.

J L Grem, G R Hafez, J H Brandenburg

    Cancer
    |May 15, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cryptococcus neoformans pericarditis associated with Hodgkin's disease.

    Annals of internal medicine·2013
    Same author

    NIH consensus development statement on management of hepatitis B.

    NIH consensus and state-of-the-science statements·2008
    Same author

    Synovial sarcoma, a primary liver tumor--a case report.

    Pathology, research and practice·2006
    Same author

    Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.

    Muscle & nerve·2004
    Same author

    Sustained partial response of an intra-abdominal desmoid tumor treated with gemcitabine, 5-fluorouracil and leucovorin.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same author

    N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2002
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Spontaneous remission is rare in aggressive lymphomas like diffuse large cell lymphoma. This case highlights an exceptional instance of spontaneous regression in Stage IIA diffuse large cell lymphoma.

    Area of Science:

    • Oncology
    • Hematology
    • Cell Biology

    Background:

    • Diffuse large cell lymphoma (DLCL) is an aggressive non-Hodgkin lymphoma.
    • Spontaneous regression, or spontaneous remission, is uncommon in aggressive lymphomas.
    • Indolent lymphomas are known to occasionally undergo spontaneous regression.

    Observation:

    • A patient with Stage IIA diffuse large cell lymphoma experienced spontaneous remission.
    • No specific treatment was administered prior to the observed remission.

    Findings:

    • This case represents an extremely rare occurrence of spontaneous regression in an aggressive lymphoma subtype.
    • Literature review confirms spontaneous regressions are well-documented in indolent lymphomas but exceptionally rare in aggressive ones.

    Related Experiment Videos

    Implications:

    • This case challenges the conventional understanding of lymphoma progression.
    • Further research is warranted to explore the mechanisms behind spontaneous regression in aggressive lymphomas.
    • Understanding these mechanisms could potentially lead to novel therapeutic strategies.